目的 分析急性心肌梗死西医治疗策略与临床预后。方法 选取青岛市黄岛区中医医院2022年1月至2023年6月100例急性心肌梗死患者,用随机数字表法分组,对照组纳入的50例运用常规治疗,观察组纳入的50例开展急诊PCI治疗,比较两组治疗有效率、心功能指标、不良反应、血管内皮功能、炎症因子水平及并发症发生率。结果 观察组治疗有效率、心功能指标、血管内皮功能、并发症发生率、炎症因子水平均优于对照组(P<0.05)。两组不良反应发生率比较无统计学意义(P>0.05)。结论 在急性心肌梗死患者治疗期间,通过予以急诊PCI治疗方式,具有改善心功能、血管内皮功能的效果,且能够降低炎症因子水平,有助于降低不良反应发生率,很大程度上提高了治疗水平。
Abstract
Objective To analyze the Western medicine treatment strategy and clinical prognosis of acute myocardial infarction. Methods A total of 100 patients with acute myocardial infarction treated from Huangdao District Hospital of Traditional Chinese Medicine of Qingdao City from January 2022 to June 2023 were selected and divided into groups by random number table method. 50 cases included in the control group received conventional treatment, and 50 cases included in the observation group received emergency PCI treatment. Comparison of treatment efficiency, cardiac function indexes, adverse reactions, vascular endothelial function, inflammatory factor levels and complication rates between the two groups. Results The treatment efficiency, cardiac function index, vascular endothelial function, complication rate and inflammatory factor level in observation group were better than those in control group (P<0.05). There was no statistical significance in the incidence of adverse reactions between the two groups (P>0.05). Conclusions During the treatment of patients with acute myocardial infarction, emergency PCI can improve the cardiac function and vascular endothelial function, reduce the level of inflammatory factors, help to reduce the incidence of adverse reactions, and improve the treatment level to a large extent, which is worthy of reference.
关键词
西医治疗 /
急性心肌梗死 /
临床预后 /
治疗效果 /
应用价值
Key words
Western medicine treatment /
Acute myocardial infarction /
Clinical prognosis /
Therapeutic effect /
Application value
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 李小霞,刘浩,姚超然,等. 替格瑞洛在急性心肌梗死多支病变患者经皮冠状动脉介入治疗术后的效果[J]. 中国心血管病研究,2024,22(9):782-788.
[2] 李春,李夏. 生长分化因子15联合沉默信息调节因子1在老年急性心肌梗死患者介入治疗的预后预测价值分析[J]. 心肺血管病杂志,2024,43(3):222-227.
[3] 刘华,张建刚,李冰,等. 不同剂量他汀类药物对经皮冠状动脉介入治疗的老年ST段抬高型急性心肌梗死患者的影响[J]. 实用临床医药杂志,2024,28(9):62-66,72.
[4] 赵玲,宋俊迎,王琼,等. 重组人脑利钠肽联合盐酸胺碘酮治疗急性心肌梗死病人急诊PCI术后新发心房颤动的疗效观察[J]. 中西医结合心脑血管病杂志,2024,22(11):2081-2084.
[5] 刘凯,陈园园,陈海燕,等. 达格列净对急性心肌梗死合并糖尿病患者经皮冠状动脉介入治疗后糖代谢和心功能的影响[J]. 西北药学杂志,2024,39(3):189-193.
[6] 邢程,薛杨静. 舍曲林联合心理治疗对合并焦虑、抑郁的急性心肌梗死患者的情绪和心功能的影响[J]. 国际精神病学杂志,2024,51(2):529-532.
[7] 徐勇刚,杨德辉,赵嫦姣,等. 通心络胶囊联合硫酸氢氯吡格雷片治疗急性心肌梗死PCI术后患者的临床效果[J]. 临床合理用药,2024,17(15):44-46.
[8] 蔡文玉,张登庆,丁育钧,等. 注射用重组人脑利钠肽在中青年急性心肌梗死经皮冠状动脉介入治疗术后心力衰竭患者的临床疗效观察[J]. 北方药学,2024,21(7):182-184.